通过促进miR-34b/HSPG2轴,FOXO3可以抑制淋巴瘤的进展
Shi Tao1, Qianlei Huang1, Weilun Zhou1
1Department of Hematology, Hainan Province Clinical Medical Center, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China.
International journal of laboratory hematology
|May 22, 2024
概括
作为瘤抑制剂的FOXO3在扩散性大B细胞淋巴瘤 (DLBCL) 中被降低. 抑制FOXO3抑制DLBCL细胞的增殖,并通过miR-34b/HSPG2通路促进细胞亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因法规 基因法规
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种流行且经常致命的淋巴细胞恶性瘤.
- 在许多癌症中,FOXO3的瘤抑制作用已被确立,但其在DLBCL中的功能尚不清楚.
研究的目的:
- 研究FOXO3在扩散大B细胞淋巴瘤中的作用和潜在机制.
- 在DLBCL进展中阐明涉及FOXO3,miR-34b和HSPG2的调节轴.
主要方法:
- 对FOXO3表达和患者预后的生物信息分析.
- 定量实时PCR和西式涂抹来评估基因和蛋白质水平.
- 细胞增殖 (CCK-8) 和细胞亡 (流细胞计) 的测定.
- 双 luciferase 报告员,ChIP 和 RIP 测试以验证分子相互作用.
主要成果:
- 在DLBCL细胞中,FOXO3表达显著下降.
- 过度表达FOXO3抑制DLBCL细胞增殖并增强细胞亡,miR-34b抑制可以逆转这些效应.
- miR-34b模仿抑制DLBCL细胞恶性瘤,这种效应被HSPG2过度表达所废除.
- FOXO3直接诱导miR-34b的表达,miR-34b的目标是HSPG2.
结论:
- 在DLBCL中,FOXO3作为瘤抑制剂,通过抑制细胞增殖和促进细胞亡.
- FOXO3/miR-34b/HSPG2通路是DLBCL进展的关键调节者.
- 针对FOXO3/miR-34b/HSPG2轴可能为DLBCL提供治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


